Cleared Traditional

ENZYMUN TEST R IGE (K896902) - FDA 510(k) Clearance

Class II Immunology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K896902 · Boehringer Mannheim Corp. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1990
Decision
33d
Days
Class 2
Risk

K896902 is an FDA 510(k) clearance for the ENZYMUN TEST R IGE. Classified as System, Test, Radioallergosorbent (rast) Immunological (product code DHB), Class II - Special Controls.

Submitted by Boehringer Mannheim Corp. (Indianapolis, US). The FDA issued a Cleared decision on January 10, 1990 after a review of 33 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5750 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boehringer Mannheim Corp. devices

Submission Details

510(k) Number K896902 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 08, 1989
Decision Date January 10, 1990
Days to Decision 33 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
71d faster than avg
Panel avg: 104d · This submission: 33d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DHB System, Test, Radioallergosorbent (rast) Immunological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - DHB System, Test, Radioallergosorbent (rast) Immunological

All 58
Devices cleared under the same product code (DHB) and FDA review panel - the closest regulatory comparables to K896902.
SPECIFIC ALLERGEN MODULES FOR ALASTAT ALLERGEN IGE
K910075 · Diagnostic Products Corp. · Jan 1991
ADD MIX ALLERGEN PANEL MOD ALASTAT(R) ALLERGEN IGE
K903742 · Diagnostic Products Corp. · Oct 1990
ALASTAT ALLERGEN-SPEC IGE CONTROL DC1A/2A/6A/NGCA
K902576 · Diagnostic Products Corp. · Sep 1990
3M MULTI-ALLERGEN IGE FASTSCREEN S7, (G3,4,5,6,8)
K897145 · 3M Company · Jan 1990
28 ADDITIONAL ALLERGEN MODULES FOR ALASTAT(TM)
K884883 · Diagnostic Products Corp. · Jan 1989
MIXED ALLERGEN PANEL MODULES FOR ALASTAT(TM)
K884923 · Diagnostic Products Corp. · Jan 1989